Femasys Corp (FEMY): Debts to Book Capitalization

Brandmark of Femasys Inc (FEMY)

Robotic capacities in Georgia ensure a stable output of instruments, which correlates with the capital structure risk metric on the balance sheet, where the value of 1.25 characterizes this level. Femasys Inc. (FEMY) management is focused on the imminent acquisition of clearances for the implementation of minimally invasive systems. Commercial development relies on current office solutions for contraception and infertility diagnostics.

FEMY (Femasys Corporation) Debt to Book Value history from 07/04/2022 to 10/27/2026
Original product of Femasys Corporation

For Femasys Inc., which implements AI modules and billing systems, the balance of borrowed funds is critically important when scaling software. This ratio compares total liabilities to equity on the balance sheet. By analyzing the trend of the total debt-to-equity ratio, an investor assesses the degree of financial leverage. A decrease in this indicator minimizes bankruptcy risk but limits growth rates. The current capital structure determines the company's stability during its period of technological transformation.

Who Femasys Inc. competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value MBOT|Debt to Book Capitalization Ratio Pro-Dex Corp PDEX|Debt to Book Value Ratio Zentek Corp ZTEK|Debt to Book Value Elutia Inc. (ELUT)|milestonescientific.com - Debt to Book Capital|Debt to Book Capitalization Ratio NXGL (NEXGEL)|RVP - Debts to Net Assets|Debts to Book Capitalization Harvard Bioscience, Inc. (HBIO)|Meihua Medical Technologies Co., Ltd. (MHUA) - Debts to Book Capitalization Ratio|Debts to Book Capitalization POAI (Predictive Oncology Inc)|Debts to Book Value CJMB|Debt to Book Capitalization Ratio ATRI (Atrion)|Debt to Book Value NeuroMetrix Inc (NURO)